Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Molecular Templates, Inc.Listing unverified | Buy | $86.3K | conv 19 | SEC | |
Strongbridge Biopharma plcListing unverified | Buy | $55.7K | conv 21 | SEC | |
KALA BIO, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
KALA BIO, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
KALA BIO, Inc.Listing on record | Buy | $3.2M | conv 65ClusterFirst in 12mo | SEC | |
Celator Pharmaceuticals IncListing unverified | BuyD (derivative) | $75K | ClusterFirst in 12mo | SEC |